Comparison of 4- and 4 plus-courses S-1 administration as adjuvant chemotherapy for pancreatic ductal adenocarcinoma

Abstract Purpose The study aimed to investigate the potential benefit of more than 4 courses of S1 adjuvant chemotherapy for patients with pancreatic ductal adenocarcinoma (PDAC) after surgery. Method Data were retrospectively collected from consecutive patients who underwent S-1 adjuvant chemothera...

Description complète

Détails bibliographiques

Auteurs principaux:	Bo Li, Shuo Shen, Siting You, Guoxiao Zhang, Suizhi Gao, Xiaohan Shi, Huan Wang, Xiaoyi Yin, Xiongfei Xu, Shiwei Guo, Gang Jin
Format:	Artigo
Langue:	Inglês
Publié:	BMC 2021-05-01
Collection:	BMC Cancer
Sujets:	Pancreatic ductal adenocarcinoma Prognosis S-1 Adjuvant chemotherapy
Accès en ligne:	https://doi.org/10.1186/s12885-021-08380-9
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!